Company Biography
Evaluation of Early Risk of Moderate-to-Severe Cytokine Release Syndrome (CRS) Induced by CAR T-Cell Therapy using Pooled Clinical Trial Data
Link to Abstract. A PDF of the poster is available to download under the Resources tab
Contact Information
Name
Robert R. Buderi
Email
robbie.buderi@3ds.com
You have chosen to your
information with
Evaluation of Early Risk of Moderate-to-Severe Cytokine Release Syndrome (CRS) Induced by CAR T-Cell Therapy using Pooled Clinical Trial Data
Team Members
Robert Buderi
Medidata Solutions, a Dassault Systemes Company
Sr. Data Scientist